| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 1.35B | 40.31B | 41.04B | 41.33B | 37.76B | 36.47B |
| Gross Profit | 1.35B | 37.89B | 40.93B | 41.19B | 37.52B | 36.06B |
| EBITDA | -21.48B | -22.22B | 4.43B | 5.29B | 5.67B | 5.49B |
| Net Income | -21.65B | -22.33B | 2.10B | 2.65B | 3.63B | 2.08B |
Balance Sheet | ||||||
| Total Assets | 3.58T | 3.33T | 3.31T | 3.28T | 3.52T | 3.26T |
| Cash, Cash Equivalents and Short-Term Investments | 0.00 | 699.67B | 585.71B | 572.44B | 895.52B | 658.86B |
| Total Debt | 229.30B | 33.36B | 34.13B | 41.75B | 313.80B | 132.73B |
| Total Liabilities | 3.42T | 3.18T | 3.16T | 3.12T | 3.35T | 3.09T |
| Stockholders Equity | 154.12B | 151.49B | 150.20B | 153.41B | 161.29B | 167.16B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 0.00 | -1.36B | -292.20B | 278.43B | 316.46B |
| Operating Cash Flow | 0.00 | 0.00 | 1.10B | -290.89B | 279.58B | 317.90B |
| Investing Cash Flow | 0.00 | 217.17B | -35.63B | -32.44B | -42.96B | -43.85B |
| Financing Cash Flow | 0.00 | 5.82B | 51.05B | -904.00M | -545.00M | -1.68B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | ¥867.01B | 9.65 | 8.19% | 3.14% | 15.77% | 27.55% | |
75 Outperform | ¥102.02B | 1.54 | ― | 3.05% | 8.75% | -12.68% | |
69 Neutral | ¥100.70B | 6.66 | ― | 2.46% | 9.12% | 43.43% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
64 Neutral | ¥1.17T | 11.66 | ― | 2.00% | 18.45% | 41.89% | |
60 Neutral | ¥95.73B | 7.75 | ― | 3.35% | 15.96% | 81.27% | |
52 Neutral | ¥99.76B | 6.95 | ― | 2.12% | 10.91% | -1225.48% |